Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0359020110420050323
Korean Journal of Gastrointestinal Endoscopy
2011 Volume.42 No. 5 p.323 ~ p.326
A Case of Pancreatic Cancer and Opioid Withdrawal after Endoscopic Ultrasound-guided Celiac Plexus Neurolysis
Seol Soo-Hwan

Kim Hyun-Soo
Hwang Byung-Sik
Oh Dae-Myung
Baek In-Yub
Park Min-Kyu
Ryu Hyon-Uk
Kwon Jong-Kyu
Abstract
Pancreatic cancer is usually unresectable upon diagnosis, and treatment aims to optimize the quality of the patient¡¯s life by managing symptoms, and, particularly, by providing adequate pain control. When the pain is refractory to opioids, interventions such as celiac plexus neurolysis (CPN) can be considered. Endoscopic ultrasound (EUS)-guided CPN has been introduced for pancreatic cancer. Reported herein is a case of a 75 year-old man with pancreatic cancer who was treated with opioids due to severe abdominal pain. EUS-guided CPN was performed for pain control, and the opioid administration was discontinued as the pain improved dramatically. However, the patient experienced opioid withdrawal symptoms, including anxiety, insomnia, nausea, and vomiting. Thus, although EUS-guided CPN successfully reduced pain in a patient undergoing such treatment and to whom opioid was administered, opioid administration should not be abruptly discontinued. Rather, the opioid dose should be reduced gradually to avoid drug withdrawal.
KEYWORD
Endoscopic-ultrasound-guided celiac plexus neurolysis, Pancreatic cancer, Opioid withdrawal
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø